Published in Gastroenterology Week, February 6th, 2012
"Smith (AGS) has shown its inhibiting effect on TNF-a, IL-1ß and HMGB1 release in vitro in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.